A founder of the Company in 2000, she was Chief Scientific Officer from 2000 until 2 November 2020, is a member of Oryzon’s Board of Directors since its foundation and is the First Vice Chair, and is also the President of the company’s Scientific Advisory Board since November 2020. She received her PhD. in Biotechnology (genetics) from the University of Ghent (Belgium). She is also a director of MENDELION LIFESCIENCES, S.L., she was a member of the Scientific Advisory Board of the Consejo Superior de Investigaciones Científicas (CSIC) since January 20, 2009, through January 22, 2013, is a member of the Scientific Review Board of the Alzheimer’s Drug Discovery Foundation since 2016 and has collaborated with CAIXA CAPITAL RISC in its mentoring program for new entrepeneurs since September 1, 2015.
First appointment as Director: 20 february 2002
Re-election: 02 september 2020
Company shares: CNMV